Class 4 caution in use-Gepretix 100mg capsules

Exeltis UK Limited has informed the MHRA regarding an inconsistency in the Patient Information Leaflet (PIL) packaged in cartons of the specified batches of Gepretix 100mg capsules.

MHRA drug alert date: 1st February 2024

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-exeltis-uk-limited-gepretix-100mg-capsules-el-24-a-slash-04#contents

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact Uk.medinfo@exeltis.com or telephone 01494411775.

For stock control enquiries please contact uk.office@exeltis.com